Drug Type Small molecule drug |
Synonyms Cholyl-lysyl-fluorescein, Fluorescein Lisicol |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC51H63N3O11S |
InChIKeyKHNJPPGHIWPDLG-DXNXUNFASA-N |
CAS Registry140616-46-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Phase 3 | DE | 01 Mar 2008 | |
Liver Cirrhosis | Phase 3 | DE | 01 Mar 2008 | |
Chronic viral hepatitis | Phase 2 | BG | 01 Mar 2009 | |
Chronic viral hepatitis | Phase 2 | RO | 01 Mar 2009 | |
Hepatitis C, Chronic | Phase 2 | BG | 01 Mar 2009 | |
Hepatitis C, Chronic | Phase 2 | RO | 01 Mar 2009 | |
Nonalcoholic Steatohepatitis | Phase 2 | US | 01 Jun 2008 | |
Chronic liver disease | Phase 2 | BG | 01 Aug 2004 |